Visar Belegu, Ph.D.

Affiliations: 
2004 University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States 
Area:
Molecular Biology, Biochemistry
Google:
"Visar Belegu"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Robert H. Broyles grad student 2004 University of Oklahoma Health Sciences Center
 (A new function of heavy chain ferritin: Repressor of beta-globin.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Broyles RH, Joshi SK, Curtis CD, et al. (2014) Edx-17: A Novel, Safe and Efficacious Treatment for Sickle Cell Disease Blood. 124: 1357-1357
Broyles R, Belegu V, Roth A, et al. (2010) A developmental switch yields a treatment for beta thalassemias and sickle cell disease Developmental Biology. 344: 525
Broyles RH, Roth AC, Todd M, et al. (2006) Nuclear reprogramming by cell fusion. Methods in Molecular Biology (Clifton, N.J.). 325: 47-57
Broyles RH, Belegu V, Roth AC, et al. (2006) Ferritin Heavy Chain Stimulates HbS-to-HbF Switching in Erythroid Precursor Cells from Sickle Cell Patients. Blood. 108: 790-790
Broyles RH, Belegu V, Stewart CA, et al. (2004) Ferritin Heavy Chain, a Repressor of the Human β-Globin Gene That Binds a Conserved Cagtgc Motif, Is Bound to the Repressed β-Globin Promoter In Vivo in K562 Cells and Specifically Binds an Analogous Site in the Mouse β Major -Globin Promoter. Blood. 104: 1223-1223
Broyles RH, Belegu V, DeWitt CR, et al. (2001) Specific repression of beta-globin promoter activity by nuclear ferritin. Proceedings of the National Academy of Sciences of the United States of America. 98: 9145-50
See more...